Funding

Active external funded projects:

  • University of Oslo, Life Science, Convergence Environment: Fibro-PET (2022-27) 
    FIBRO-PET: Novel personalized management strategies for fibrosing diseases
     
  • Oslo University Hospital strategic research area (2022-27) (Co-PI)
    FIBRO-MAN: Personalized management strategies for fibrosing diseases
    Integration of novel imaging techniques into clinical management in fibrosing diseases
     
  • RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI)
    TARACAN: Targeted Radionuclide Therapy for disseminated cancer 
     
  • South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) 
    Theranostic radiopharmaceuticals for metastatic cancer 
     
  • South-Eastern Norway Regional Health Authority (2019-2024)
    A novel PET-based prediction platform for myeloma patients
     
  • South-Eastern Norway Regional Health Authority and CarciNor (2018-24)
    Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
     
  • Civitan, The Alzheimer Research Fund (2018-2023)
    Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels
 
Page visits: 590